Théa is a company with deep European roots, whose independence, stability, and entrepreneurial spirit are ensured by the Chibret family, which has been leaving its mark on ophthalmology for over 150 years. This family governance prioritizes the long-term development of the Théa group and its employees to fulfill its mission: to be THE essential specialist in ophthalmology.
Our vision
Our mission and our values
A unique vision of ophthalmology
The current trend among pharmaceutical laboratories is to focus on a few molecules, targeting limited therapeutic areas.
For over 30 years, Théa has chosen to assert its generalist vocation and today offers the most complete and modern range of ophthalmic treatments. All areas of eye health are covered, including allergies, infections and antibiotic therapy, glaucoma, inflammation, and dry eye…
The Théa group is continuously innovating while also ensuring the maintenance of older products that still hold therapeutic value for healthcare professionals, whether in the diagnosis of ophthalmic pathologies or in the treatment of eye infections.
Théa is also interested in rare and orphan eye diseases. These diseases often affect very few patients worldwide; however, Théa invests in research to alleviate or even combat these conditions.
The revolution of "preservative-free"
For several years, concerns have been growing about the health effects of the repeated and daily use of chemical additives such as preservatives, oxidants, and colorants. Evidence of harmful effects on both humans and the environment is increasing.
As early as 1994, Henri Chibret became a pioneer by removing preservatives and creating the ABAK®, the first multidose eye drop bottle capable of delivering preservative-free drops. This world first, developed by Théa, ushered in a new era for ophthalmology—the era of "preservative-free."
Théa's R&D teams have successfully concentrated ten years of research and technological innovation into the ABAK®. This system allows for a shelf life of up to six months without the addition of preservatives.
Since then, Théa has continued its revolution of "preservative-free" by developing new formulas and products. This commitment has been recognized by numerous health authorities worldwide, which now recommend "preservative-free" options in eye care.
Théa acts to give EVERY GENERATION the opportunity to OPEN THEIR EYES WIDE to a SUSTAINABLE world.
Innovation
As a pioneer in preservative-free treatments, Théa's primary commitment is to provide healthcare professionals and patients with:
- Innovative products.
- A wide range of specialties (service products, daily care, etc.).
- Across all therapeutic classes in ophthalmology.
Théa is determined to relentlessly pursue research to offer new treatments and innovative modes of administration. Innovation remains the top priority for the group, which reinvests more than 10% of its revenue into R&D each year.
At Théa, innovation is a constant mindset, always seeking new solutions to address untreated conditions or improve their management. Théa is thus a pioneer in several therapeutic segments of eye health. Its objectives are to:
- Continue partnerships and collaborative research.
- Share its knowledge with as many people as possible.
- Address unmet medical needs to provide new treatment methods or patient support.
Internationalization
Already present in 75 countries, Théa is not stopping there. The group aims to expand and strengthen its global presence. This international deployment is based on two strategic axes:
- Staying at the forefront of innovation in a context where the acquisition of new knowledge has accelerated.
- Developing new territories. The ocular health of tomorrow will be shaped by advances in gene therapy and the rise of digital health.
Currently the leading independent laboratory in Europe, Théa also aspires to become a global leader by continuing to export its products and establish a presence internationally, always respecting local cultures and practices.
Education
Education and training are deeply rooted in Théa's DNA. The group maintains its commitment to impart and promote the sharing of knowledge among both young ophthalmologists and experienced practitioners.
Based on the principle that ocular health is evolving and that knowledge in ophthalmology is continually expanding, the group is multiplying actions and initiatives to train, educate, promote research, and pass on knowledge.
This is exemplified by the establishment of Théa Academy, the educational program specifically aimed at young practitioners.
Excellence
Laboratoires Théa are recognized worldwide for the seriousness, quality, and excellence of their products and practices.
At the same time, aware of the multiple challenges related to sustainable development, the group has committed to a societal and environmental approach focused on three pillars:
- Ophthalmology: Develop, apply, and promote responsible practices at every stage of the product life cycle for the benefit of healthcare professionals.
- Employees: Foster the growth and well-being of Théa employees around the world.
- Ecosystem: Contribute to the societal and economic development of the Théa ecosystem and to the preservation of natural resources wherever the group operates.
To learn more about our CSR commitments:
Long-term vision, closeness, and entrepreneurial spirit. That’s what sets us apart!